Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.00
Bid: 27.00
Ask: 29.00
Change: 0.00 (0.00%)
Spread: 2.00 (7.407%)
Open: 28.00
High: 28.00
Low: 28.00
Prev. Close: 28.00
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Joint Development agreement with Energizer

2 Feb 2012 07:00

RNS Number : 6494W
Ilika plc
02 February 2012
 



Ilika plc

("Ilika" or the "Company")

 

Joint Development agreement with Energizer

 

Ilika plc (AIM: IKA), the advanced cleantech materials discovery company, announces that it has entered into a joint development agreement with Energizer Battery Manufacturing Inc., in the USA, a world leading primary battery manufacturer, for the development of advanced materials.

 

Commenting on the contract, Graeme Purdy, CEO of Ilika, said: "We are delighted to have entered into this new commercial relationship with Energizer and become part of its global innovation network. Energizer has a clear vision for its next generation of products and well defined channels to market."

 

An Energizer spokesperson said: "Ilika's high throughput techniques are well-matched to our material development requirements and we look forward to rapid innovation in this collaboration."

 

For more information contact:

 

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director

 

 

 

Nomura Code Securities Limited (NOMAD)

Tel: 020 7776 1200

Phil Walker / Christopher Golden

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780

Paul McManus

Mob: 07980 541 893 or paul.mcmanus@walbrookpr.com

Paul Cornelius

Mob: 07827 879 460 or paul.cornelius@walbrookir.com

 

 

ABOUT ILIKA

 

Ilika is an advanced materials company which accelerates the discovery of new and patentable materials using its unique high throughput technologies (''HTT'') process for identified end uses in the energy, electronics and biomedical sectors. This process enables hundreds of scalable materials to be made in a single, automated operation and subsequently tested for key properties.

 

Traditionally, materials development has been a slow and arduous task, with manual, sequential methods used to make samples of material that are then tested for suitability. On average, it takes between 7 and 10 years to move from an initial discovery through to the first commercial prototype. Experiments carried out by the Company can be executed 10 to 100 times faster than using traditional techniques.

 

The Company focuses on three principal sectors and has a number of active development programmes addressing markets within each sector:

 

Energy - developing innovative new materials for Lithium-ion batteries for vehicles for Toyota; developing high capacity hydrogen storage materials with Shell Hydrogen and Johnson Matthey through joint development programmes; developing cheaper alternatives to Platinum electrodes for use in fuel cells through a grant-funded project with the Carbon Trust; developing new materials for use in fuel cells for the transport sector for a major vehicle manufacturer; and carrying out in-house research on film photovoltaic solar cells.

 

Electronics - developing lead-free piezoelectric materials through a joint development programme with CeramTec; developing phase change memory materials for high capacity memory chips and high-performing electronic materials for a multi-national manufacturer.

 

Biomedical - developing polymers to enable the filtering of somatic stem cells from blood with a major global supplier of filters; it has been selling its Cryoskin and Myskin products for the treatment of burns and wounds in the UK through a specialist distributor and intends to commence clinical trials of its corneal bandage candidate.

 

The Group's commercialisation strategy is to enter into joint development or licensing agreements with large multinational companies which are seeking to commercialise products developed using the intellectual property created through jointly-funded programmes. Current commercialisation partners include large multinational companies such as Toyota, Shell, Johnson Matthey and CeramTec. The Company generates revenues from three sources: licensing and milestone payments from joint development programmes; fee for service from contract research projects; and from sales of Cryoskin and Myskin.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRUASKRUBAURAR
Date   Source Headline
20th Oct 20162:59 pmRNSHolding(s) in Company
18th Oct 201611:45 amRNSHolding(s) in Company
18th Oct 201610:10 amRNSHolding(s) in Company
17th Oct 20162:43 pmRNSResult of General Meeting
30th Sep 20167:00 amRNSPosting of Circular
29th Sep 20163:10 pmRNSResult of AGM
27th Sep 20167:00 amRNSPlacing
19th Sep 20167:00 amRNSVapour Deposition Method European Patent Grant
31st Aug 20167:00 amRNSPosting of Annual Report & Notice of AGM
16th Aug 20167:00 amRNSGrant Award
8th Jul 20167:00 amRNSFinal Results
5th Jul 20167:00 amRNSGrant of Battery Patent in China
24th Jun 20167:00 amRNSNotice of Results
27th Apr 20167:00 amRNSIlika transforms battery technology for IoT
25th Apr 20165:56 pmRNSExercise of Options and Total Voting Rights
11th Apr 20162:06 pmRNSAnalyst and Investor presentation
15th Mar 20167:00 amRNSLaunch of battery technology at IDTechEx
25th Feb 20167:00 amRNSGrant Award
16th Feb 20168:33 amRNSExercise of Options and Total Voting Rights
12th Jan 20167:00 amRNSHalf Yearly Report
4th Dec 20157:00 amRNSTrading Update
30th Nov 20156:07 pmRNSHolding(s) in Company
3rd Nov 20151:53 pmRNSDirector/PDMR Shareholding
21st Oct 20151:00 pmRNSDirector/PDMR Shareholding
12th Oct 20154:08 pmRNSExercise of Options and Total Voting Rights
1st Oct 20153:38 pmRNSGrant of Options
30th Sep 20153:14 pmRNSResult of AGM
30th Sep 20157:00 amRNSAGM Statement
29th Sep 20157:00 amRNSPatent Grant for solid-state batteries in China
22nd Sep 20157:00 amRNSGrant awarded to research self-healing alloys
4th Sep 20157:00 amRNSPosting of Annual Report & Notice of AGM
13th Aug 20157:00 amRNSUpdate on fuel cell catalyst patent in Europe
10th Jul 20157:01 amRNSDirectorate Change
10th Jul 20157:00 amRNSFinal Results
16th Jun 20157:00 amRNSNotice of Results
22nd Apr 20157:00 amRNSInvestor teach-in
16th Apr 20153:59 pmRNSHolding(s) in Company
16th Apr 20151:51 pmRNSHolding(s) in Company
16th Apr 20151:33 pmRNSHolding(s) in Company
10th Apr 201512:29 pmRNSHolding(s) in Company
26th Mar 20157:00 amRNSStart of solid-state battery pilot production
25th Mar 20159:31 amRNSHolding(s) in Company
23rd Mar 201510:36 amRNSHolding(s) in Company
17th Mar 20157:00 amRNSUpdate on patents for solid-state batteries
5th Mar 201511:03 amRNSHolding(s) in Company
4th Mar 20155:59 pmRNSDirectors Dealings, Exercise of Options & TVR
27th Feb 20157:00 amRNSGrant of Share Options
22nd Jan 20157:00 amRNSHalf Yearly Report
21st Jan 20152:48 pmRNSConversion of Securities
5th Jan 201511:43 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.